Danish pharmaceutical giant Novo Nordisk is suing US-based Eli Lilly in a New Jersey court for "false and misleading" advertisements. Novo Nordisk alleges Eli Lilly used "outdated studies" to compare GLP-1 agonist drugs like Wegovy and Ozempic to Mounjaro and Zepbound, causing confusion.
Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.
Novo Nordisk ha demandado a Eli Lilly en EE.UU. por presunta publicidad engañosa, alegando que Lilly compara sus tratamientos para la obesidad y diabetes con dosis antiguas de Novo Nordisk para mostrar resultados superiores. La disputa se da en la carrera por liderar el creciente mercado de fármacos contra la obesidad.
Novo Nordisk has filed a lawsuit in the US against Eli Lilly, accusing its rival of false advertising regarding the superiority of its weight-loss drugs, Mounjaro and Zepbound. Novo Nordisk claims Eli Lilly compared lower doses of Novo Nordisk's drugs with higher doses of its own, omitting newer options.
Novo Nordisk has filed a lawsuit against Eli Lilly in a U.S. court, alleging that Lilly's advertising campaigns for its obesity and diabetes drugs, Zepbound and Mounjaro, mislead consumers by using outdated clinical trials to compare efficacy against Novo's rival injections, Wegovy and Ozempic.
Eli Lilly is acquiring psychedelic drug maker AtaiBeckley for up to $3.8 billion, indicating Big Pharma's growing interest in these treatments for mental health. This follows positive clinical trial results and a Trump executive order to fast-track FDA reviews, despite past regulatory hurdles.
Ozivy, fabricado pela EMS, foi incluído na Lista de Medicamentos de Referência da Anvisa. Isso permite que outros laboratórios desenvolvam versões genéricas ou similares do medicamento no futuro, que tem o mesmo princípio ativo do Ozempic.
William Gusmão, irmão da influenciadora Virginia Fonseca, foi condenado por importunação sexual em Jussara, Goiás. A vítima, Lilly Martins, relatou dois episódios de assédio durante uma festa. A defesa de William alega inocência e pretende recorrer da decisão.
The family of Lilly Jones, a 14-year-old girl found dead in Duffryn Park, has paid tribute to her, describing her as "the most beautiful, kind and caring little girl". A 14-year-old boy has been charged with her murder, with the preliminary cause of death being multiple stab wounds. Her family expressed their heartbreak and thanked the community for their support.
The family of 14-year-old Lilly Jones, found dead in Duffryn Park, Blaenau Gwent, last month, described her as "the most beautiful, kind and caring little girl". A 14-year-old boy has been charged with her murder, with a preliminary cause of death cited as multiple stab wounds.
An inquest heard that 14-year-old Lilly Jones, reported missing from Blaina, was found dead in Duffryn Park woodlands with multiple stab wounds. A 14-year-old boy has been charged with her murder.
A 14-year-old girl, Lilly Jones, reported missing from Blaina, was found dead in Duffryn Park woodlands with multiple stab wounds. A 14-year-old boy has been charged with her murder, and an inquest has been opened.
A 14-year-old girl, Lilly Jones, reported missing from Blaina, was found dead in Duffryn Park woodlands with multiple stab wounds to the neck and torso. A 14-year-old boy has been charged with her murder.
Medicare is launching the Bridge demonstration program to cover GLP-1 obesity drugs for eligible beneficiaries with a $50 monthly copay, a first for the program. This temporary initiative, set to expire in 2027, could unlock millions of new patients for Novo Nordisk and Eli Lilly, but raises concerns about healthcare system strain and long-term patient access.
The FDA has chosen seven companies, including Eli Lilly and Regeneron, for its PreCheck pilot program to speed up reviews of new domestic pharmaceutical manufacturing facilities. The initiative aims to cut review times by up to 14 months by allowing construction-phase inspections.
Medicare's Bridge program starts covering obesity drugs for eligible beneficiaries with a $50 monthly copay, but 82% of older Americans are unaware of this new coverage.
A RAISE US, uma nova organização bipartidária nos EUA, foi lançada com mais de US$ 500 milhões para investir em educação e capacitação profissional. Fundada por Gina Raimondo e Eric Holcomb, a iniciativa visa ajudar trabalhadores americanos a migrarem para novas carreiras em uma economia automatizada pela IA, começando por programas em quatro estados.
A 14-year-old boy has been charged with murder following the discovery of a body in Duffryn Park, Blaina, South Wales. Police believe the body is that of Lilly, also 14, who was reported missing. The accused has been remanded in custody.
A single 79-year-old patient received early access to Eli Lilly's experimental obesity drug retatrutide through the FDA's compassionate use program. The unusual case has sparked speculation about the patient's identity, with questions raised if it could be former President Donald Trump.
A 14-year-old boy has been arrested on suspicion of murder after the body of a missing 14-year-old girl, Lilly, was found in Duffryn Park, Blaina, South Wales. Police are appealing for information and urging the public not to speculate online.
Casos de lesão hepática foram registrados em Victoria, Austrália, após o uso de produtos com retatrutida, substância para obesidade e diabetes. Autoridades suspeitam de contaminantes em versões ilegais comercializadas online.
Stocks were mixed Tuesday as the S&P 500 dipped, with tech notably lagging. SpaceX's market cap surged past Amazon and briefly Microsoft. Eli Lilly acquired 4E Therapeutics to bolster its pain treatment pipeline. Broadcom saw insider buying amid a post-earnings sell-off.
Drugmakers are exploring new obesity treatments beyond GLP-1s, including less frequent shots and pills with fewer side effects. Eli Lilly's experimental drug retatrutide showed significant weight loss, while competitors like Novo Nordisk, Structure Therapeutics, AstraZeneca, Pfizer, and Amgen are developing new oral and injectable options. The market is expected to grow significantly, with pricing and insurance coverage being key factors.
Pharmaunternehmen Eli Lilly und Boehringer Ingelheim reduzieren geplante Investitionen in Deutschland aufgrund von Sparplänen der Bundesregierung. Ministerpräsident Schnieder versucht zu vermitteln, während die Koalition in Berlin vor einem Dilemma steht.
